Kilter Group’s CONMED CNMD Stock Holding History

Kilter Group’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.23K	Buy	63 +19	+43%	+$773	﹤0.01%	908
2025 Q4	$1.79K	Buy	+44	New	+$1.91K	﹤0.01%	843

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Kilter Group's CNMD Position: Q1 2026 in Review

Kilter Group increased its CONMED (CNMD) stake by 43% in Q1 2026, buying an estimated $773 and bringing the position to 63 shares worth $2.23K. The position accounts for ﹤0.01% of the portfolio, ranked #908.

Kilter Group first reported a position in CNMD in Q4 2025 and has held it in 2 quarters since. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

Kilter Group held 63 shares of CONMED worth $2.23K as of Q1 2026.
Kilter Group bought 19 CONMED shares in Q1 2026, an estimated $773.
CONMED made up ﹤0.01% of Kilter Group's portfolio in Q1 2026, its #908 holding.
Kilter Group first reported a position in CONMED in Q4 2025 and has held it in 2 quarters since.
236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Kilter Group's 13F filing for Q1 2026, filed 14 May 2026.